Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Más información
| Título de la Revista: | Circulation |
| Volumen: | 132 |
| Asunto: | 8 |
| Fecha de publicación: | 2015 |
| Página de inicio: | 32 |
| Página final: | 624 |
| DOI/URL: |
10.1161/CIRCULATIONAHA.114.014807 |